share_log
Breakings ·  05:02
Ultragenyx Pharmaceutical Inc: Reaffirmed 2024 Expected Total Revenue Guidance of $530 Mln to $550 Mln
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment